EUVIMEDScopri EUVIMED
Leserbrief

Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Authors' Reply

Yu-Sheng Lin, Ying-Cheng Lin, Teng-Yu Lee iD

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1443-1444

DOI: 10.1111/apt.70643 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-27. Written by Yu-Sheng Lin and 2 co-authors. Institution: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 10 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Subjects

Author keywords

genetic risk scorehepatitis Chepatocellular carcinoma

Authors and institutions

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, Chung Hsing University, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

ORCID profiles: Teng-Yu Lee

Cite

APA

Lin, Y. S., Lin, Y. C., & Lee, T. Y. (2026). Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(10), 1443-1444. https://doi.org/10.1111/apt.70643

Vancouver

Lin YS, Lin YC, Lee TY. Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(10):1443-1444. doi:10.1111/apt.70643

BibTeX
@article{Lin2026,
  author = {Lin, Yu-Sheng and Lin, Ying-Cheng and Lee, Teng-Yu},
  title = {Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1443--1444},
  doi = {10.1111/apt.70643}
}
Start for free →